Thursday broker round-up - UPDATE

Admiral: Oriel Securities retains sell rating and 740p target.AstraZeneca: Panmure Gordon maintains buy rating and 3,600p target.Barclays: Nomura reiterates neutral rating and 268p target; Exane BNP Paribas keeps outperform rating and 300p target; Oriel Securities keeps buy rating and 285p target; Seymour Pierce keeps hold rating and 200p target; Investec keeps buy rating and 240p target.Berendsen: Seymour Pierce downgrades from buy to add, 545p target kept.Capita: UBS cuts target from 725p to 700p, neutral rating kept.Dixon Retail: AlphaValue downgrades to from buy to add, raises target to €21.30 from €21.20.Howden Joinery: Espirito Santo reiterates buy recommendation and 150p target.HSBC: Exane BNP Paribas keeps outperform rating and 675p target.GlaxoSmithKline: Panmure Gordon reiterates hold rating and 1,450pt argot.Go-Ahead Group: Panmure Gordon cuts target from 1,450p to 1,250p, hold recommendation kept.Ladbrokes: Nomura raises target from 135p to 150p, neutral rating unchanged.Lloyds: Exane BNP Paribas keeps outperform rating and and 45p target.UBM: Nomura ups target from 665p to 675p, buy rating kept.Unilever: Panmure Gordon reiterates buy rating and 2,300p target.Whitbread: Panmure Gordon maintains hold rating and 1,768p target; Shore Capital maintains buy rating.William Hill: Nomura lifts target from 190p to 205p, reduce rating unchanged.BC